Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate.

Abstract

We report the case of a 2-month-old boy with unilateral pharmacologic mydriasis from inadvertent exposure to glycopyrronium after parental use of glycopyrronium wipes. Clinician familiarity with the potential effects of glycopyrronium exposure may aid in the recognition, diagnosis, and prevention of pharmacologic mydriasis as well as the reduction of costly and unnecessary evaluations.

• Authors: Steven Seto, Alison A Teo, Ryan D Walsh
• Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus (J AAPOS) Vol. 23 Issue 6 Pg. 359-361 (12 2019) ISSN: 1528-3933 [Electronic] United States
• PMID: 31683011 (Publication Type: Case Reports, Journal Article)
• Copyright: Published by Elsevier Inc.

Chemical References

• Cholinergic Antagonists
• glycopyrronium tosylate
• Glycopyrrolate

Topics

• Administration, Topical
• Cholinergic Antagonists (administration & dosage)
• Glycopyrrolate (administration & dosage)
• Humans
• Infant
• Male
• Mydriasis (chemically induced, diagnosis, physiopathology)
• Parents
• Pupil (drug effects)